Novasure

One-Step Urine HCG Pregnancy Test Kit from Novala Biotech is a rapid and reliable in vitro diagnostic tool designed for the early detection of pregnancy

HIV-1 and HIV-2 Rapid Test Kit

Novala HIV-1 and HIV-2 Test Kit is a rapid, 3rd generation, qualitative, sandwich immunoassay designed for the simultaneous and differential detection of total antibodies (IgG, IgM, IgA, etc.) to HIV

HBsAg Rapid Test Kit

The HBsAg Rapid Test Kit is a qualitative immunoassay designed for the detection of Hepatitis B surface antigen (HBsAg) providing a rapid and reliable method for the diagnosis of Hepatitis B infection.

Syphilis Rapid Test Kit

The Syphilis Rapid Test Kit is a reliable method for the diagnosis of syphilis. It is qualitative immunoassay designed for the detection of antibodies to Treponema pallidum, the causative agent of syphilis.

HCV Rapid Test Kit

The HCV Rapid Test Kit provides a convenient and reliable method for the diagnosis of Hepatitis C infection. It is a rapid, qualitative immunoassay designed for the detection of antibodies to Hepatitis C Virus (HCV)

H. pylori Antigen Rapid Test Kit

The H. pylori Antigen Rapid Test Kit is a qualitative immunoassay designed for the detection of antigen to Helicobacter pylori (H. pylori)

Testimonials

We have worked with many clients and we always like to hear they come out from the cooperation happy and satisfied. Have a look what our clients said about us.

Are you looking for distributorship?

If you want to build your business in In vitro diagnostic kits

Do contact us

From our blog

Novala introduces cutting edge technology in Nepal for the first time against AMR

on May 30, 2024

Novala Biotech has introduced a cutting edge technology in Nepal which is expected to help to manage Antimicrobial resistant bacteria prevalent in Nepal. Novala Biotech in collaboration with Center for American Medical specialist ( CAMS clinic) has introduced the latest FDA-approved Point-of-Care (POC) diagnostic test for Antimicrobial Resistance (AMR) to Nepal. This marks a monumental achievement, as it not only represents the first time this technology has been brought to Nepal but also the second instance in all of South East Asia region.

Continue reading

Influenza antigen kit Type A and Type B

on April 20, 2024

Novala is proud to introduce latest product: the Influenza A&B Rapid Test Kit. This advanced diagnostic tool is designed to swiftly and accurately detect the presence of Influenza A and B antigens in nasopharyngeal swab, throat swab, or nasal aspirate specimens. With its user-friendly design and reliable results, our test kit offers a convenient solution for healthcare professionals in the rapid diagnosis of influenza.\ Precautions: It is important to follow some precautions to ensure accurate results and maintain safety:

Continue reading

Novala Biotech's Scientific Presentation on National Health Research Summit

on April 11, 2024

As the vibrant energy of the 10th National Summit of Health and Population Scientists in Nepal enveloped the venue, our team from Novala Biotech embarked on a journey that would redefine our understanding of healthcare innovation. Led by Dr. Sunita Gautam, our esteemed Chairperson and Chief Technical Officer, and Mr. Kabin Maleku, our visionary Director of Operations, we stepped onto the stage with a sense of purpose and determination. Standing before a diverse audience of researchers and industry experts, we unveiled our scientific poster – a culmination of months of relentless dedication and unwavering passion.

Continue reading

H PYLORI ANTIGEN TEST KITS: REVOLUTIONIZING PRECISION AND ACCESSIBILITY IN H PYLORI DIAGNOSTICS

on February 3, 2024

Helicobacter pylori, a Gram-negative bacterium with significant implications for public health, is the culprit behind gastritis, peptic ulcers, and, alarmingly, has been classified as a Class 1 carcinogen due to its link to cancer. Novala Biotech, committed to advancing diagnostics, has introduced H Pylori antigen test kits, boasting unparalleled sensitivity, specificity, and affordability compared to existing methods, making them a game-changer in the landscape of STI diagnostics. Unmasking the Prevalence of H.

Continue reading